Yimin Li

Active 1996–2026

245
Papers
28,127
Citations
68
h-index
193
i10-index

Citations

Citations per year for Yimin Li1982: 1 citations1991: 1 citations1999: 1 citations2001: 3 citations2002: 1 citations2003: 1 citations2004: 1 citations2005: 3 citations2007: 4 citations2008: 2 citations2009: 9 citations2010: 15 citations2011: 25 citations2012: 32 citations2013: 40 citations2014: 45 citations2015: 49 citations2016: 52 citations2017: 78 citations2018: 81 citations2019: 222 citations2020: 2,749 citations2021: 2,437 citations2022: 1,210 citations2023: 698 citations2024: 922 citations2025: 479 citations2026: 34 citations1983–1990: no citations, so these years are not shown1992–1998: no citations, so these years are not shown2000: no citations, so this year is not shown2006: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,684 citing papers, 19.9% of this breakdownUnited States: 2,174 citing papers, 16.1% of this breakdownUnited Kingdom: 779 citing papers, 5.8% of this breakdownItaly: 604 citing papers, 4.5% of this breakdownIndia: 591 citing papers, 4.4% of this breakdownGermany: 418 citing papers, 3.1% of this breakdownSpain: 378 citing papers, 2.8% of this breakdownCanada: 371 citing papers, 2.8% of this breakdownFrance: 358 citing papers, 2.7% of this breakdownAustralia: 310 citing papers, 2.3% of this breakdownIran: 298 citing papers, 2.2% of this breakdownBrazil: 235 citing papers, 1.7% of this breakdown
0%19.9%Other 31.7%

Fields

  • Medicine64.7%
  • Biochemistry, Genetics and Molecular Biology10.2%
  • Mathematics5.7%
  • Engineering4.8%
  • Computer Science3.5%
  • Immunology and Microbiology2.6%
  • Other8.5%

Topics

  • COVID-19 Clinical Research Studies12.6%
  • SARS-CoV-2 and COVID-19 Research7.5%
  • Long-Term Effects of COVID-195.5%
  • COVID-19 epidemiological studies3.1%
  • COVID-19 and healthcare impacts2.4%
  • COVID-19 diagnosis using AI2.2%
  • Other66.7%

Coauthors

All papers

Open in search
  1. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

    Authors: , , , , - Intensive Care Medicine 2020 cited by 2,822

  2. Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Disease 2020 cited by 1,502

  3. Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer

    Authors: , , , , , , , , , , , , , , - Signal Transduction and Targeted Therapy 2022 cited by 151

  4. Exuberant fibroblast activity compromises lung function via ADAMTS4

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gwenn E. McLaughlin, Matthew L. Paden, Keiko M. Tarquinio, Bria M. Coates, Neethi Pinto, Juliane Bubeck Wardenburg, Adrienne G. Randolph, Anna A. Agan, Tanya Novak, Margaret M. Newhams, Stephen C. Kurachek, Mary E. Hartman, Allan Doctor, Edward J. Truemper, Sidharth Mahapatra, Kate G. Ackerman, L. Eugene Daugherty, Mark W. Hall, Neal J. Thomas, Scott L. Weiss, Julie C. Fitzgerald, Renee A. Higgerson, Laura L. Loftis, Rainer Gedeit, Marc-André Dugas, Thomas N. Wight, Stacey Schultz‐Cherry, Stephania A. Cormier, Kathryn Shaw‐Saliba, Andrew Pekosz, Richard E. Rothman, Kuan‐Fu Chen, Zifeng Yang, Richard J. Webby, Nanshan Zhong, Jeremy Chase Crawford, Paul G. Thomas - Nature 2020 cited by 226

  5. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , - JAMA Internal Medicine 2020 cited by 1,519

  6. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2010 cited by 802

  7. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peng Peng, Jian Ming Wang, Jiyang Liu, Zhong Chen, Gang Li, Zhi-jian Zheng, Shao-qin Qiu, Jie Luo, Chang-jiang Ye, Shao-yong Zhu, Lin-ling Cheng, Feng Ye, Shi-yue Li, Jin-ping Zheng, Nuo-fu Zhang, Nanshan Zhong, Jian-xing He - European Respiratory Journal 2020 cited by 3,771

  8. Emerging mechanisms of lipid peroxidation in regulated cell death and its physiological implications

    Authors: , , , , - Cell Death and Disease 2024 cited by 240

  9. Ferroptosis, pyroptosis and necroptosis in acute respiratory distress syndrome

    Authors: , , , , , - Cell Death Discovery 2023 cited by 63

  10. Cloud-Edge Collaborative SFC Mapping for Industrial IoT Using Deep Reinforcement Learning

    Authors: , , , , , - IEEE Transactions on Industrial Informatics, IEEE Trans. Ind. Informatics 2021 cited by 62

  11. Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yunsong Yu, Minggui Wang - Journal of Microbiology Immunology and Infection 2023 cited by 134

  12. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mariah Leidinger, Jiekai Chen, Yimin Li, Nanshan Zhong, David K. Meyerholz, Paul B. McCray, Stanley Perlman, Jincun Zhao, Jincun Zhao - Cell 2020 cited by 494

  13. Long-Term Efficacy of a Hepatitis E Vaccine

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 373

  14. Intracellular and Extracellular Lipopolysaccharide Signaling in Sepsis: Avenues for Novel Therapeutic Strategies

    Authors: , , , , , - Journal of Innate Immunity 2021 cited by 142

  15. Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Molecular Therapy 2018 cited by 114

  16. Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Qiu-Fen Zhang, Guang Sun, Fengcai Zhu, Shaowei Li, Yimin Li, Huirong Pan, Jun Zhang, You‐Lin Qiao, Ningshao Xia - The Lancet Infectious Diseases 2022 cited by 89

  17. Activation of CncC pathway by ROS burst regulates cytochrome P450 CYP6AB12 responsible for λ-cyhalothrin tolerance in Spodoptera litura

    Authors: , , , , , - Journal of Hazardous Materials 2019 cited by 128

  18. Early triage of critically ill COVID-19 patients using deep learning

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nanshan Zhong, Junzhou Huang, Jianxing He - Nature Communications 2020 cited by 304

  19. Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guo-Qi Gao, Ba-Yi Li, Bin Zhao, Fengxian Zheng, Cui-Hong Dai, Meng Guo, Jun Zhao, Yingying Su, Junzhi Wang, Fengcai Zhu, Shaowei Li, Huirong Pan, Yimin Li, Jun Zhang, Ningshao Xia - JNCI Journal of the National Cancer Institute 2019 cited by 179

  20. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery

    Authors: , , , , , , , , , - Journal of Ethnopharmacology 2016 cited by 246

  21. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Lin, Yun Ling, Haofei Liu, Jianwei Liu, Nianping Liu, Shu‐Qiang Liu, Meng Luo, Qiang Ma, Song Qibing, Wujianan Sun, Gaoxiang Wang, Feng Wang, Ying Wang, Xiaofeng Wen, Qian Wu, Gang Xu, Xiaowei Xie, Xinxin Xiong, Xudong Xing, Hao Xu, Chonghai Yin, Dongdong Yu, Kezhuo Yu, Jinbo Yuan, Biao Zhang, Peipei Zhang, Tong Zhang, Jincun Zhao, Peidong Zhao, Peidong Zhao, Wei Zhou, Wei Zhou, Xiaosong Zhong, Shuye Zhang, Shuye Zhang, Ping Zhu, Bin Zou, Jiahua Zou, Jiahua Zou, Zengtao Zuo, Fan Bai, Xi Huang, Penghui Zhou, Qinghua Jiang, Zhiwei Huang, Lai Wei, Lai Wei, Xiu-Wu Bian, Xindong Liu, Tao Cheng, Xiangpan Li, Pingsen Zhao, Pingsen Zhao, Fang Wang, H Wang, Kun Qu, Zheng Zhang, Kun Qu, Xiaoqun Wang, Jiekai Chen, Ronghua Jin, Zemin Zhang - Cell 2021 cited by 194

  22. Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell Reports Medicine 2023 cited by 67

  23. The metabolic resistance of Nilaparvata lugens to chlorpyrifos is mainly driven by the carboxylesterase CarE17

    Authors: , , , - Ecotoxicology and Environmental Safety 2022 cited by 40

  24. Kinetics of viral load and antibody response in relation to COVID-19 severity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Huibin Lv, Yongliang Jiang, Min Li, Yimin Lin, Ying Deng, Lan Tang, Jieling Liang, Jicheng Huang, Stanley Perlman, Nanshan Zhong, Jingxian Zhao, Malik Peiris, Yimin Li, Jincun Zhao - Journal of Clinical Investigation 2020 cited by 602